| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine and pharmaceutical industry and represents a method of treating ptosis in an individual, involving administration of an effective amount of oxymetazoline or its pharmaceutically acceptable salts and an effective amount of phenylephrine or its pharmaceutically acceptable salt into an external surface of eye of an individual in need of the above treatment.EFFECT: invention ensures the absence of clinically significant mydriasis and the improved field of vision.24 cl, 3 dwg, 7 tbl, 10 ex |
